Apple Watch Series 4 to track ECGOctober 10, 2018
The US Food and Drug Administration has cleared the Apple Watch Series 4 to operate as an OTC device to monitor ECG.
The FDA approval makes Apple Watch the first device available to consumers over the counter to monitor ECG.
The new Apple Watch Series 4 version has electrodes placed in the sapphire crystal and digital crown that allows users to take an ECG at any time using the app provided. The Apple Watch can show its first ECG to users without a doctor review.
The Health app allows all ECG recordings stored in so that they can be shared with healthcare professionals at a later time.
Apple plans to add more capabilities in the device later this year to aid detect atrial fibrillation.
Health-care products on ubiquitous devices, like smart watches, may help users seek treatment earlier and will empower them with more information about their health, the FDA Commissioner Scott Gottlieb said in a statement. “The FDA worked closely with the company as they developed and tested these software products, which may help millions of users identify health concerns more quickly,” he added.
The Apple Watch Series 4 line starts at $399. It is $70 more than the starting price of last year’s model.